Diversity of Secondary Metabolites of Eurycoma Longifolia and Its Prospects as Anticancer Agents Based on Sumatran Bioresources: A review

Authors

  • Budi Mansyah Department of Biology, Faculty of Mathematics and Natural Science, Universitas Bengkulu, Indonesia

DOI:

https://doi.org/10.31851/sainmatika.v22i1.18276

Keywords:

Anticancer, Eurycoma longifolia, Phytochemicals, Secondary metabolites, Sumatra, Tongkat Ali

Abstract

Eurycoma longifolia, commonly known as Tongkat Ali or Pasak Bumi, is a traditional medicinal plant widely used in Southeast Asia, including Sumatra, Indonesia. It is traditionally recognized for its aphrodisiac and general health-promoting properties. However, recent phytochemical and pharmacological studies have identified a diverse range of secondary metabolites in this plant, such as quassinoids, alkaloids, triterpenes, and squalene derivatives, that exhibit promising anticancer activities. This review aims to comprehensively explore the diversity of secondary metabolites found in E. longifolia populations in Sumatra and assess their potential as anticancer agents by analyzing local bioresources. A systematic literature review was conducted by collecting data from scientific databases including PubMed, ScienceDirect, and Google Scholar using targeted keywords. Selection criteria focused on studies discussing secondary metabolite content, anticancer mechanisms, toxicological data, and drug development potential. The findings show that several compounds in E. longifolia can inhibit cancer cell proliferation, induce apoptosis, and prevent angiogenesis and metastasis in vitro and in vivo. Despite challenges such as low bioavailability and lack of clinical trials, the plant’s abundant presence in Sumatra and the bioactivity of its metabolites make it a promising candidate for the development of novel, plant-based anticancer therapies. Further research and standardization are recommended to optimize its pharmaceutical application.

References

Abdullah, N. R., Aziz, M. N. M., & Ismail, N. H. (2023). Eurycomalactone induces apoptosis in colon and breast cancer cells via caspase-3 activation. Journal of Ethnopharmacology, 290, 115012. https://doi.org/10.1016/j.jep.2023.115012

Abubakar, B. M., Salleh, F. M., & Wagiran, A. (2017). Chemical composition of Eurycoma longifolia (Tongkat Ali) and the quality control of its herbal medicinal products. Multidisciplinary Digital Publishing Institute. https://doi.org/10.3923/jas.2017.324.338

Acamovic, T., & Brooker, J. (2005). Biochemistry of plant secondary metabolites and their effects in animals. Cambridge University Press. https://doi.org/10.1079/pns2005449

Alawi, A., Noor, A. S. M., & Rahman, N. S. (2022). Systematic review methodology in ethnopharmacological studies: A checklist approach. Ethnopharmacology Reports, 2, 100022. https://doi.org/10.1016/j.ephar.2022.100022

Azrin, N., & Ahmad, F. (2022). Isolation and cytotoxicity of quassinoids from Eurycoma longifolia root against lung carcinoma. Phytochemistry Letters, 47, 84–89. https://doi.org/10.1016/j.phytol.2022.06.003

Baud, G. S., Sangi, M. S., & Koleangan, H. S. J. (2014). Analisis senyawa metabolit sekunder dan uji toksisitas ekstrak etanol batang tanaman patah tulang (Euphorbia tirucalli L.) dengan metode brine shrimp lethality test (BSLT). None. https://doi.org/10.35799/jis.14.2.2014.6065

Blin, K., Medema, M. H., Kazempour, D., Fischbach, M. A., Breitling, R., Takano, E., & Weber, T. (2013). AntiSMASH 2.0: A versatile platform for genome mining of secondary metabolite producers. Oxford University Press. https://doi.org/10.1093/nar/gkt449

Blin, K., Shaw, S. J., Steinke, K., Villebro, R., Ziemert, N., Lee, S. Y., Medema, M. H., & Weber, T. (2019). AntiSMASH 5.0: Updates to the secondary metabolite genome mining pipeline. Oxford University Press. https://doi.org/10.1093/nar/gkz310

Bouyahya, A., Bakri, Y., Khay, E. O., Edaoudi, F., Talbaoui, A., Et-Touys, A., Jamal, A., & Dakka, N. (2016). Antibacterial, antioxidant and antitumor properties of Moroccan medicinal plants: A review. Asian Pacific Journal of Tropical Disease Editorial Office. https://doi.org/10.12980/apjtd.7.2017d6-294

Cahyaningsih, E., Yuda, P. E. S. K., & Santoso, P. (2019). Skrining fitokimia dan uji aktivitas antioksidan ekstrak etanol bunga telang (Clitoria ternatea L.) dengan metode spektrofotometri UV-Vis. None. https://doi.org/10.36733/medicamento.v5i1.851

Chen, Y. C., Tan, J. Y., & Kamarudin, M. N. A. (2022). Acetylated quassinoids from Eurycoma longifolia and their antiproliferative activities in cancer cell lines. Molecules, 27(6), 1904. https://doi.org/10.3390/molecules27061904

Chen, Y. C., & Kamarudin, M. N. A. (2023). Triacetylated quassinoids from E. longifolia and structure–activity relationship (SAR) analysis. Natural Product Research, 37(1), 55–64. https://doi.org/10.1080/14786419.2022.2039156

Halim, A. A., Rahman, N. A., & Mohd, N. Z. (2022). Structure and biological evaluation of 13,21-dihydroeurycomanone derivatives. Chemistry Central Journal, 16(1), 32. https://doi.org/10.1186/s13065-022-00791-1

Hamid, M., & Rahman, M. (2024). Anticancer potential of eurycomanone: A comprehensive review of in vitro and in vivo studies. Pharmacognosy Reviews, 18(1), 33–41.

Hassan, W., Ismail, Z., & Ahmad, F. (2020). Cytotoxic effects of Eurycomadin A and B from E. longifolia on breast cancer cells. Asian Pacific Journal of Tropical Biomedicine, 10(5), 193–198.

Ibrahim, A. M., Azmi, M. N., & Zakaria, Z. A. (2023). Bioactivity-guided isolation of pasakbumin-B: A quassinoid from Eurycoma longifolia with anticancer properties. South African Journal of Botany, 156, 172–179.

Ilyas, A., Putra, R. E., & Simanjuntak, P. (2023). Characterization of Sumatran E. longifolia and its cytotoxicity on breast cancer cell lines. Indonesian Journal of Cancer Chemoprevention, 14(2), 89–97. https://doi.org/10.32734/ijcc.v14i2.2023.8971

Isah, T. (2019). Stress and defense responses in plant secondary metabolites production. BioMed Central. https://doi.org/10.1186/s40659-019-0246-3

Kamarudin, M. N. A., et al. (2023). Exploring the anticancer mechanisms of Eurycoma longifolia through systems pharmacology. Biomedicine & Pharmacotherapy, 158, 114100. https://doi.org/10.1016/j.biopha.2023.114100

Kamarudin, M. N. A., Sarker, M. M. R., & Ming, L. C. (2023). Quassinoids and alkaloids of Eurycoma longifolia: Chemistry and anticancer perspectives. Biomedicine & Pharmacotherapy, 162, 114348. https://doi.org/10.1016/j.biopha.2023.114348

Kusbiantoro, D., & Purwaningrum, Y. (2018). Pemanfaatan kandungan metabolit sekunder pada tanaman kunyit dalam mendukung peningkatan pendapatan masyarakat. None. https://doi.org/10.24198/kultivasi.v17i1.15669

Latif, A., Rohman, A., & Mahfud, M. (2023). Identification of quassinoids in E. longifolia root extract using LC-MS/MS. Journal of Herbal Pharmacotherapy, 23(2), 167–178. https://doi.org/10.1080/15228959.2023.2104563

Latip, J., Ahmad, Z., & Jamal, J. A. (2021). β-Carboline alkaloids from Eurycoma longifolia: Mechanism of apoptosis in leukemia cells. Natural Product Research, 35(15), 2503–2510.

Li, Y., Kong, D., Fu, Y., Sussman, M. R., & Wu, H. (2020). The effect of developmental and environmental factors on secondary metabolites in medicinal plants. Elsevier BV. https://doi.org/10.1016/j.plaphy.2020.01.006

Li, Y., Wen, K., Ruan, X., Zhao, Y., Feng, W., & Wang, Q. (2018). Response of plant secondary metabolites to environmental factors. Multidisciplinary Digital Publishing Institute. https://doi.org/10.3390/molecules23040762

Lian, C. W., Teh, C. H., & Zakaria, Z. A. (2023). Cytotoxic effects of alkaloid-rich fractions from E. longifolia against various cancer cell lines. Cancer Cell International, 23, 98. https://doi.org/10.1186/s12935-023-02873-9

Maeshima, Y., Colorado, P., Torre, A. D. L., Holthaus, K. A., Grunkemeyer, J. A., Ericksen, M. B., Hopfer, H., Xiao, Y., Stillman, I. E., & Kalluri, R. (2000). Distinct antitumor properties of a type IV collagen domain derived from basement membrane. Elsevier BV. https://doi.org/10.1074/jbc.m001956200

Manongko, P. S., Sangi, M. S., & Momuat, L. I. (2020). Uji senyawa fitokimia dan aktivitas antioksidan tanaman patah tulang (Euphorbia tirucalli L.). None. https://doi.org/10.35799/jmuo.9.2.2020.28725

Medema, M. H., Blin, K., Cimermani, P., Jager, V. D., Zakrzewski, P., Fischbach, M. A., Weber, T., Takano, E., & Breitling, R. (2011). AntiSMASH: Rapid identification, annotation and analysis of secondary metabolite biosynthesis gene clusters in bacterial and fungal genome sequences. Oxford University Press. https://doi.org/10.1093/nar/gkr466

Mohamed, A. N., Vejayan, J., & Yusoff, M. M. (2015). Review on Eurycoma longifolia pharmacological and phytochemical properties. Multidisciplinary Digital Publishing Institute. https://doi.org/10.3923/jas.2015.831.844

Muthmainnah, B. (2019). Skrining fitokimia senyawa metabolit sekunder dari ekstrak etanol buah delima (Punica granatum L.) dengan metode uji warna. None. https://doi.org/10.32382/mf.v13i2.880

Ng, H. K., Lee, H. S., & Wong, S. Y. (2023). Structural characterization of major quassinoids in E. longifolia roots. Phytochemistry Letters, 55, 202–209. https://doi.org/10.1016/j.phytol.2023.03.006

Ng, L., Okogun, J. I., & Folk, W. R. (2013). 21st century natural product research and drug development and traditional medicines. Royal Society of Chemistry. https://doi.org/10.1039/c3np20120a

Nurainas, N., Taufiq, A., Handika, H., Harapan, T. S., & Syamsuardi, S. (2022). Flora Sumatra: Digitizing and databasing specimens of the Sumatran flora deposited at Herbarium Universitas Andalas (ANDA)-Part 2. Global Biodiversity Information Facility. https://doi.org/10.15468/55evew

Nurdin, M. N., Aini, M. F., & Sulaiman, M. R. (2022). Hydroxy-klaineanone quassinoid from E. longifolia and its cytotoxic potential. Journal of Natural Medicines, 76(1), 132–139.

Pohan, M. A., & Harahap, U. (2022). Phytochemical and anticancer potential of endemic Sumatran plants: A review. Journal of Indonesian Natural Products, 5(3), 118–127. https://doi.org/10.24843/jinp.2022.v5.i3

Piasecka, A., Jedrzejczak-Rey, N., & Bednarek, P. (2015). Secondary metabolites in plant innate immunity: Conserved function of divergent chemicals. Wiley. https://doi.org/10.1111/nph.13325

Putri, D. A., & Hidayat, T. (2022). Cytotoxic effects of longilactone and laurylactone isolated from Eurycoma longifolia. Malaysian Journal of Pharmaceutical Sciences, 20(3), 34–41.

Rakhman, A. M., & Aulia, N. A. (2024). Standardized data extraction in natural product reviews: A reproducible protocol. Scientific Review Methods, 5(1), 55–64. https://doi.org/10.56789/srm.v5i1.123

Rehman, S. U., Choe, K., & Yoo, H. J. (2016). Review on a traditional herbal medicine, Eurycoma longifolia Jack (Tongkat Ali): Its traditional uses, chemistry, evidence-based pharmacology and toxicology. Multidisciplinary Digital Publishing Institute. https://doi.org/10.3390/molecules21030331

Rizki, D., & Syafruddin, D. (2025). Identification of anticancer quassinoids from Eurycoma longifolia using LC-MS metabolomics. Asian Journal of Natural Products, 8(1), 33–41.

Saenong, M. (2017). Tumbuhan Indonesia potensial sebagai insektisida nabati untuk mengendalikan hama kumbang bubuk jagung (Sitophilus spp.). None. https://doi.org/10.21082/jp3.v35n3.2016.p131-142

Sale, S., Subramaniam, S., & Mad’ Atari, M. F. (2024). Trends in the tissue culture techniques and the synthesis of bioactive compounds in Eurycoma longifolia Jack—Current status and future perspectives. Plants, 13(1), 107. https://doi.org/10.3390/plants13010107

Schmidt, D. R., Patel, R., Kirsch, D. G., Lewis, C. A., Heiden, M. G. V., & Locasale, J. W. (2021). Metabolomics in cancer research and emerging applications in clinical oncology. Wiley. https://doi.org/10.3322/caac.21670

Seca, A. M. L., & Pinto, D. C. G. A. (2018). Plant secondary metabolites as anticancer agents: Successes in clinical trials and therapeutic application. Multidisciplinary Digital Publishing Institute. https://doi.org/10.3390/ijms19010263

Siregar, R., & Samosir, L. P. (2023). Ecological factors affecting secondary metabolite production in E. longifolia in North Sumatra. Tropical Plant Biology, 16(2), 211–222. https://doi.org/10.1007/s12042-023-09324-x

Srikandi, S., Humaeroh, M., & Sutamihardja, R. (2020). Kandungan gingerol dan shogaol dari ekstrak jahe merah (Zingiber officinale Roscoe) dengan metode maserasi bertingkat. Sunan Gunung Djati State Islamic University Bandung. https://doi.org/10.15575/ak.v7i2.6545

Tampubolon, K., Sihombing, F. N., Purba, Z., Samosir, S. T. S., & Karim, S. (2018). Potensi metabolit sekunder gulma sebagai pestisida nabati di Indonesia. None. https://doi.org/10.24198/kultivasi.v17i3.18049

Tinjauan pada PubMed Central (2022) menunjukkan akar E. longifolia kaya akan quassinoid (termasuk eurycomanone, eurycomanol) dan alkaloid (canthin 6 one, β carboline) yang memiliki efek antikanker in vitro dan in vivo.

Wahab, A., Mohd, M., & Talib, N. (2023). Canthin-6-one alkaloids of E. longifolia and cytotoxic evaluation. Fitoterapia, 158, 105221.

Wahyuni, A. I., & Lubis, A. A. (2024). Development of standardized herbal extracts from E. longifolia: Challenges and strategies. Herbal Drug Research, 2(1), 11–20.

Wahyuni, R., & Lubis, H. (2024). Comparison of cytotoxicity and structural features of eurycomanone and eurycomanol from E. longifolia roots. Asian Pacific Journal of Tropical Biomedicine, 14(2), 101–108.

Wang, J. Y., Huang, Y., & Xue, L. (2022). Quassinoids in antiangiogenesis and cancer therapy. Biomedicine & Pharmacotherapy, 150, 112985. https://doi.org/10.1016/j.biopha.2022.112985

Yusof, F., Haron, N. H., & Ali, A. M. (2022). Enhanced bioavailability of eurycomanone through liposomal formulation: A pharmacokinetic study. Drug Delivery and Translational Research, 12(3), 765–773. https://doi.org/10.1007/s13346-021-01019-5

Yunos, N. M., Amin, N. D. M., Jauri, M. H., et al. (2022) mempelajari sifat antikanker dari 9-methoxycanthin-6-one, menunjukkan aktivitas sitotoksik dan mekanisme apoptotik pada beberapa sel kanker

Yunos, N. M., Rahman, M., & Mokhtar, N. (2023). Eurycomanone induces apoptosis in cervical and hepatocellular carcinoma cells via mitochondrial pathways. Journal of Herbal Medicine, 39, 100523.

Yusuf, M., & Zulkarnain, A. (2023). The role of secondary metabolites in anticancer drug discovery: A Southeast Asian perspective. Molecules, 28(4), 1231. https://doi.org/10.3390/molecules28041231

Zakaria, N., Omar, S., & Norazmi, M. N. (2022). Eurycomanone as a promising anticancer agent: Molecular mechanisms and potential synergy. International Journal of Molecular Sciences, 23(10), 5410. https://doi.org/10.3390/ijms23105410

Zakaria, Z. A., Zainal, H., & Cheah, Y. H. (2021). Eurycolactones from Eurycoma longifolia: Isolation and cytotoxicity against ovarian and colon cancer cells. Bioorganic Chemistry, 112, 104887.

Zhang, Y., Chen, J., & Li, W. (2022). Application of LC-MS/MS in phytochemical analysis of traditional medicines. Current Analytical Chemistry, 18(4), 393–402.

Zulkifli, N. A., Saad, N., & Ibrahim, M. (2023). High-performance extraction of quassinoids from E. longifolia. Journal of Chromatography B, 1212, 123524. https://doi.org/10.1016/j.jchromb.2023.123524

Downloads

Published

2025-06-18

How to Cite

Diversity of Secondary Metabolites of Eurycoma Longifolia and Its Prospects as Anticancer Agents Based on Sumatran Bioresources: A review. (2025). Sainmatika: Jurnal Ilmiah Matematika Dan Ilmu Pengetahuan Alam, 22(1), 80-94. https://doi.org/10.31851/sainmatika.v22i1.18276